Hetero COVID drug Molnupiravir shows positive results in Phase III trials Ruchika Sharma21 Feb 2022 4:37 PM ISTHyderabad: Hetero, a globally renowned vertically integrated pharmaceutical organization has recently announced the positive results of Phase III...
Health Bulletin 3/January/2022 Dr. Nandita Mohan3 Jan 2022 7:45 PM ISTHere are the Top Health stories of the dayIndia's Omicron count crosses 1,700-markNMC nod to DM cardiology course at PGIMS RohtakIn a major milestone...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Raid on Hetero Pharma Group: IT Dept detects Rs 550 crore hidden income, seizes Rs 142 crore cash Medical Dialogues Team10 Oct 2021 10:30 AM ISTNew Delhi: The Income Tax Department detected "unaccounted" income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided...
Covid-19: India likely to allow export of Sputnik Light this month Ruchika Sharma24 Sept 2021 10:00 AM ISTNew Delhi: India is likely to allow the export of domestically produced doses of Russia's Sputnik Light COVID-19 vaccine this month, as the shot has...
Hetero gets CDSCO panel nod to manufacture Sputnik V for restricted emergency use Medical Dialogues Team21 Sept 2021 4:20 PM ISTNew Delhi: In a significant development, drug firm Hetero has got the green signal from the Subject Expert Committee (SEC) functional under the...
Hetero gets DCGI emergency use approval for Tocilizumab biosimilar for Covid-19 Ruchika Sharma6 Sept 2021 3:36 PM ISTNew Delhi: Drug firm Hetero on Monday said it has received emergency use authorisation from Drug Controller General of India (DCGI) for its biosimilar...
Hetero announces interim clinical results of Molnupiravir in COVID patients in India Ruchika Sharma9 July 2021 2:31 PM ISTHyderabad: Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from...
NPPA fixes retail price of 12 formulations, Details Medical Dialogues Team6 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla, Mylan, others directed to allocate Remdesivir to states, UTs as per Govt supply plan Medical Dialogues Team9 May 2021 11:15 AM ISTNew Delhi: In continuation of the allocation plan of Remdesivir drug for the period 21st April to 9th May, the Ministry of Health and Family Welfare...
CDSCO panel nod to phase 3 trials of Sputnik V by Hetero Pharma Medical Dialogues Team30 April 2021 3:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has given a green signal to Hetero...
Govt directs Sun Pharma, Cipla, 5 others to ramp up Covid drug remdesivir production to full capacity Ruchika Sharma8 April 2021 5:03 PM ISTMandaviya said these seven manufacturers- Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy''s, Zydus Cadila and Sun Pharma - have a monthly...
